A recent episode involving Galgotias University has triggered a wider national debate on transparency, regulatory oversight, and accountability in India’s fast-growing medical technology sector. What initially appeared to be a localized institutional matter has rapidly evolved into a broader discussion among policymakers, healthcare leaders, regulators,
The Centre has worked with over 20 startups and 35 industry partners; providing end-to-end support ranging from industrial design and rapid prototyping to machining, post-processing and production.Strengthening India’s journey towards self-reliance in medical device manufacturing, the Advanced Additive Manufacturing Centre of Excellence (Coe) at Andhra
The Yamuna Expressway Industrial Development Authority (YEIDA) is all set to sign a Memorandum of Understanding (MoU) with a leading Japanese government agency — the Japan External Trade Organization (JETRO) — to collaborate on the development of a state-of-the-art Medical Device Park along the Yamuna
India’s healthcare stakeholders — including hospitals, diagnostic chains, medical device firms, insurers and pharma groups — have responded positively to the rollout of GST 2.0, saying the tax changes announced under Prime Minister Narendra Modi’s leadership will alleviate cost pressures, expand access, and give a
Poly Medicure Limited (Polymed), one of India’s leading medical device companies, today announced the acquisition of Citieffe Group, an Italy-based company specializing in orthopedic trauma and extremities devices, for an enterprise value of approximately ₹324 crore (€31 million).The acquisition has been executed through Medistream SA,
India’s ambitious efforts to lower its reliance on medical device imports are being curbed by stringent Production Linked Incentive (PLI) scheme requirements and persistent infrastructure underutilization, according to a recent report by the Boston Consulting Group (BCG). The report, titled “Unlocking ‘India for the World’
In a landmark move to safeguard the quality and reliability of diagnostic tools in Indian healthcare, the Central Drugs Standard Control Organisation (CDSCO), in partnership with the Indian Council of Medical Research (ICMR), has released comprehensive draft standard evaluation protocols for issuing licenses to In-Vitro
Domestic manufacturers welcome greater market access, urge careful monitoring of import dynamics and regulatory alignment India’s medical device manufacturers have voiced their support for the proposed India-UK Free Trade Agreement (FTA), citing expanded opportunities for global collaboration and technology transfer. However, industry stakeholders also stressed the
This marks Poly Medicure’s first off-site solar PPA AMPIN is the trusted renewable energy partner for leading healthcare companies, with a strong track record of repeat customers Poly Medicure Ltd. a leading medical device manufacturer has signed a Power Purchase Agreement (PPA) with AMPIN Energy
The Medical Technology Association of India (MTaI), representing leading research-based medical technology companies, emphasizes the need for a balanced assessment of the Central Drugs Standard Control Organization's (CDSCO) role in regulating medical devices and drugs. MTaI acknowledges recent reforms aimed at enhancing operational efficiency and
